Form 4: Cirrus Logic Director Alexander Davern Reports Routine Stock Transactions

Sentiment:

Insider Transaction Report


Cirrus Logic Director Alexander Davern reported the vesting of previously granted restricted stock units and the acquisition of new units following his re-election to the Board.

Summary

  • Director Alexander M. Davern acquired 1,624 shares of Cirrus Logic common stock on July 26, 2025, resulting from the vesting of previously granted restricted stock units.
  • Following this transaction, Davern beneficially owns 22,531 shares of common stock.
  • On July 29, 2025, Davern was granted 1,998 new restricted stock units upon his re-election to Cirrus Logic, Inc.'s Board of Directors.
  • These new restricted stock units will vest on the earlier of the Company's next Annual Meeting or July 29, 2026.

Sentiment

Score: 6

Explanation: The filing is neutral to slightly positive, reflecting routine insider compensation and continued director commitment, which are generally viewed as stable indicators. It does not contain any negative operational or financial news.

Positives

  • Director Alexander M. Davern continues to hold a significant stake in the company, with 22,531 shares of common stock beneficially owned, indicating continued alignment with shareholder interests.
  • The grant of new restricted stock units to Director Davern upon re-election signifies ongoing commitment to the company and aligns his compensation with long-term performance.

Future Outlook

The vesting schedule for the newly granted restricted stock units indicates a future milestone for Director Davern's compensation, with full vesting expected by July 29, 2026, or the Company's next Annual Meeting.

Industry Context

This filing represents a routine insider compensation event for a director of a semiconductor company. Such equity grants are common practice to align director interests with long-term shareholder value in the technology sector.

Comparison to Industry Standards

  • The grant of restricted stock units as part of director compensation is a standard practice across publicly traded companies, including those in the semiconductor industry such as NVIDIA, Intel, or Qualcomm, to incentivize long-term commitment and performance.
  • The vesting schedule of approximately one year for the new RSU grant is typical for such director compensation arrangements.

Stakeholder Impact

  • Shareholders: The transactions reflect continued alignment of a director's interests with shareholders through equity ownership and future vesting incentives, which can be viewed positively for corporate governance.

Next Steps

  • Vesting of 1,998 restricted stock units on the earlier of the Company's next Annual Meeting or July 29, 2026.

Key Dates

DateDescription
07/26/2025Vesting of 1,624 restricted stock units and acquisition of 1,624 shares of common stock.
07/29/2025Grant date for 1,998 new restricted stock units upon re-election to the Board of Directors.
07/29/2026Latest vesting date for the 1,998 new restricted stock units (earlier of this date or next Annual Meeting).

Recommendation

hold

This Form 4 filing details routine insider compensation (vesting of RSUs and grant of new RSUs upon re-election) for a director. It does not contain any new material information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It simply confirms ongoing insider equity participation, which is a neutral to slightly positive signal for long-term alignment.

Keywords

Cirrus Logic, CRUS, Form 4, Insider Transaction, Restricted Stock Units, Director Compensation, Stock Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.